Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ZNF536 antisense RNA 1 (ZNF536-AS1) is an annotated long noncoding RNA transcribed from the antisense strand of the ZNF536 gene locus. There is currently no published experimental evidence detailing the function, disease association, or biomarker status of ZNF536-AS1. Most available research focuses on ZNF536, a zinc finger transcription factor involved in neurodevelopment and possibly cancer biology[1][2][3][4], but the roles of its antisense RNA remain unstudied in the literature provided. As with many antisense lncRNAs, it is possible that ZNF536-AS1 could regulate the expression of ZNF536 or neighboring genes, but this has not been demonstrated in publicly available scientific studies[5]. Key context: If you are seeking information on the transcription factor ZNF536 itself (not the antisense RNA), there is substantial information on its function as a regulator of neuronal differentiation and its potential role in various cancers and neurodevelopmental disorders[1][2][3][4]. However, "ZNF536-AS1" is distinct and presently lacks sufficient research coverage. Note: If you require information for a molecular target used in drug discovery or disease therapy, ZNF536 itself (the protein-coding gene) is the relevant entity, not ZNF536-AS1. If you need information on ZNF536 (the protein), please clarify, and a structured profile for ZNF536 can be provided. Summary of limitations: - Almost all available information is about the sense (protein-coding) gene ZNF536. - Antisense lncRNAs are a recognized class, but ZNF536-AS1 is not specifically investigated or validated as a target or biomarker in major scientific sources as of the current knowledge cutoff. If more detailed or up-to-date studies on "ZNF536-AS1" become available, these details would need to be revised accordingly.
Not known.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ZNF536 antisense RNA 1 (ZNF536-AS1).